International Congress Munich 2014


Targeting lung fibrosis: from bench to bedside

Symposium
Chairs: T. Tetley (London, United Kingdom), D. Weiss (Burlington, United States of America)
Aims: During the session, the audience will learn about new approaches for treating idiopathic pulmonary fibrosis (IPF).
Transplantation of alveolar type II cells in pulmonary fibrosis: experimental studies, MSC in IPF trials
D. Chambers (Brisbane, Australia)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Alveolar type II cell transplantation in IPF: a clinical study
A. Xaubet (Barcelona, Spain)
No content made available
No content made available
Stem cell therapy in IPF
D. Bouros (Alexandroupolis, Greece)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files
Mesenchymal stem cells and fibrotic lung diseases
M. Rojas (Pittsburgh, United States of America)
WebcastSlide presentationMultimedia files
WebcastSlide presentationMultimedia files